What is the projected growth rate for 2024–2030?

The market is forecasted to grow at a CAGR of 6.2% from 2024 to 2030, fueled by increasing demand for minimally invasive procedures.

What are the key drivers of market expansion?

Drivers include surging orthopedic and cardiovascular surgeries, adoption of absorbable products, and rising healthcare spending in emerging economies.

What challenges hinder market growth?

High product costs, stringent regulatory requirements, and competition from traditional hemostatic agents limit growth in price-sensitive regions.

Which regions are leading the market?

North America holds the largest share, followed by Europe, while Asia-Pacific is the fastest-growing region due to improving healthcare infrastructure.

Who are the top companies in this market?

Leading firms include Johnson & Johnson, Medtronic, and B. Braun, leveraging R&D investments and strategic partnerships to strengthen their portfolios.

What future opportunities exist for market players?

Opportunities arise in developing biodegradable formulations for complex surgeries and expanding into untapped markets like Latin America and Africa.

How is technology shaping this industry?

Technological innovations such as nano-coated gauze and AI-driven application tools are enhancing efficacy and adoption rates globally.

What is the regulatory landscape like?

Regulatory frameworks in the U.S. (FDA), EU (CE marking), and Asia are evolving to prioritize safety and efficacy, impacting product approvals and market entry timelines.

How will the market adapt to post-pandemic trends?

The market will likely embrace telemedicine integration and hybrid surgical models, boosting demand for efficient hemostatic solutions to reduce hospital stays.

Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value Is Forecast To Reach By 2034 With CAGR

Absorbable Hemostatic Powder and Hemostatic Gauze by Application (Hospital, Clinic, Others), by Types (Absorbable Hemostatic Powder, Absorbable Hemostatic Gauze), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Absorbable Hemostatic Powder and Hemostatic Gauze Market Size | CAGR 2019 Forecast 2033

Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Absorbable Hemostatic Powder and Hemostatic Gauze Market Overview

The Absorbable Hemostatic Powder and Hemostatic Gauze market represents a critical segment within the medical devices industry, offering innovative solutions for rapid blood loss control during surgical procedures and trauma care. As the Absorbable Hemostatic Powder and Hemostatic Gauze market size reached $533 million in 2025, driven by rising surgical volumes and advancements in biodegradable materials, the growth outlook remains robust. The market forecast projects a compound annual growth rate (CAGR) of 7.5–8.5% from 2026 to 2033, fueled by macro drivers such as aging populations, regulatory tailwinds for minimally invasive technologies, and expanding applications in orthopedic and cardiovascular surgeries.

Loading chart…

Key forces shaping the industry expansion include technology shifts toward bioabsorbable polymers and collagen-based hemostats, which reduce postoperative complications. Regulatory harmonization across regions, particularly in Europe and Asia-Pacific, is accelerating product approvals. Meanwhile, supply-chain dynamics are evolving with strategic partnerships between OEMs and raw material suppliers to ensure consistent quality. North America remains the largest market, accounting for 40% of global revenue in 2025, while Asia-Pacific is poised to outpace other regions, driven by healthcare infrastructure modernization and rising disposable incomes.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; BD; Baxter; B.Braun; Cura Medical; Meril Life Sciences; Zhonghui Shengxi; Beijing Datsing Bio-tech; Guizhou Jin Jiu Biotech; Beijing Taikesiman; Foryou Medical; Saikesaisi Holdings Group; Biotemed; Hangzhou Singclean Medical Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Innovation in Biocompatible Materials – Advances in absorbable polymer technologies, such as oxidized regenerated cellulose and gelatin-based matrices, are driving adoption of Absorbable Hemostatic Powder and Hemostatic Gauze market products. These innovations enhance patient outcomes by reducing post-operative complications, aligning with the global emphasis on minimally invasive surgeries.

Rising Trauma and Surgical Volumes – The global increase in road accidents, industrial injuries, and elective surgeries is directly boosting demand for hemostatic solutions. The Absorbable Hemostatic Powder and Hemostatic Gauze market size is expected to grow at a CAGR exceeding 7.2% through 2030, fueled by aging populations and expanding surgical caseloads in emerging economies.

Restraints2 items

High Production Costs – Complex manufacturing processes for absorbable products, coupled with stringent regulatory requirements, inflate costs. This limits market accessibility in low-income regions, where cost-sensitive healthcare providers may opt for non-absorbable alternatives.

Regulatory Hurdles – Divergent approval pathways across regions (e.g., FDA, EMA, CMDT) delay product launches. Stringent clinical validation needs for hemostatic efficacy and biocompatibility slow time-to-market, particularly for next-generation formulations.

Opportunities2 items

Expansion into Asia-Pacific Markets – Rapid healthcare infrastructure development and rising disposable incomes in India and Southeast Asia present untapped potential. Local partnerships could accelerate adoption of premium hemostatic products within this region.

Integration with Smart Surgical Platforms – Opportunities exist to embed hemostatic gauze with IoT-enabled monitoring systems for real-time bleeding control feedback. This aligns with the trend toward data-driven surgical workflows and enhances product differentiation.

Challenges2 items

Competition from Generic Alternatives – Low-cost non-absorbable gauze and powder variants from unbranded manufacturers threaten profit margins. Maintaining a premium value proposition in price-sensitive markets remains a strategic challenge.

Supply Chain Vulnerabilities – Disruptions in raw material sourcing (e.g., gelatin from bovine sources) and geopolitical tensions pose risks to consistent production. Diversifying supplier networks is critical to mitigate these risks.

Market Segmentation

Loading chart…

The Absorbable Hemostatic Powder market exhibits distinct Absorbable Hemostatic Powder and Hemostatic Gauze segmentation based on Application and Types. By application, the market is dominated by surgical procedures (35%), particularly cardiothoracic and orthopedic surgeries, where rapid clot formation is critical. Trauma and emergency care (25%) and neurosurgery (15%) follow, driven by the need for biodegradable solutions in high-bleeding-risk scenarios. Dental and maxillofacial applications (10%) contribute to niche demand. By Types, the powder is classified into cellulose-based (40%) and gelatin-derived (30%) formulations, with synthetic polymers (20%) and chitosan-based variants (10%) emerging in specialized uses. These subtypes reflect material innovation tailored to absorption rates and tissue compatibility, directly influencing market size through clinical adoption and regulatory approvals.

The Hemostatic Gauze segment is similarly shaped by market taxonomy across Application and Types. Trauma and emergency care (40%) is the largest application, owing to gauze’s role in battlefield and pre-hospital bleeding control. Post-operative wound management (30%) and dental procedures (15%) drive steady demand, while veterinary and non-human applications (15%) occupy a smaller share. By Types, oxidized cellulose-based gauze (50%) dominates due to its cost-effectiveness and availability, while chitosan-based variants (25%) and collagen-coated gauze (20%) cater to advanced wound healing needs. Hybrid subtypes (5%) address specialized indications. This segmentation underscores material science advancements and application-specific efficacy, aligning with procedural requirements and regulatory frameworks.

Absorbable Hemostatic Powder and Hemostatic Gauze Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Absorbable Hemostatic Powder

Absorbable Hemostatic Gauze

Regional Insights

Loading chart…

North America dominates the Absorbable Hemostatic Powder and Hemostatic Gauze market, accounting for 40% share, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and stringent regulatory frameworks ensuring product quality. The region’s strong R&D ecosystem and strategic investments in medical device innovation further accelerate market growth.

Asia Pacific is the fastest-growing region, with a projected CAGR of 12.5% through 2030. Key drivers include rising healthcare expenditure, a growing aging population, and increasing surgical volumes due to expanding urbanization. Countries like India and China are prioritizing healthcare modernization, boosting demand for advanced hemostatic solutions.

Regional Drivers & Trends5 items

North America: High adoption rates, robust reimbursement policies, and a mature medical device ecosystem.

Europe: Regulatory harmonization (e.g., MDR compliance), public-private partnerships, and aging demographics fuel demand.

Asia Pacific: Demographic growth, rising disposable incomes, and government initiatives like India’s PLI scheme for medtech manufacturing.

Latin America: Infrastructure upgrades and growing awareness of minimally invasive surgical techniques.

Middle East & Africa: Healthcare expansion projects (e.g., Saudi Vision 2030) and increasing FDI in medical infrastructure.

The global regional forecast highlights Asia Pacific’s potential to challenge North America’s dominance by 2030, supported by its ecosystem maturity and cost-effective manufacturing hubs. Conversely, Latin America and MEA remain niche markets but show promise due to improving healthcare access and policy reforms.

Competitive Landscape

The Absorbable Hemostatic Powder and Hemostatic Gauze competitive landscape is moderately consolidated, with a mix of global players and regional firms. Major multinational corporations such as Johnson & Johnson, BD, and Baxter dominate in North America and Europe through established distribution networks and regulatory approvals. Regional manufacturers, including Meril Life Sciences and Guizhou Jin Jiu Biotech, leverage cost-competitive production and localized partnerships to capture emerging markets. Key competitive levers include product innovation (e.g., biocompatible formulations), pricing strategies, and regulatory compliance, with differentiation driven by technology (e.g., absorbable polymer patents) and partnerships with healthcare providers.

Strategic initiatives focus on R&D for next-generation hemostatic materials, geographic expansion, and OEM collaborations to reduce costs. Companies like B. Braun and Cura Medical prioritize vertical integration to mitigate supply chain risks, while others such as Beijing Datsing Bio-tech emphasize localized manufacturing for faster market access. A persistent challenge is margin pressure in price-sensitive regions, exacerbated by increasing demand for cost-effective alternatives. Competitive differentiation also hinges on service models, including customized solutions for surgical specialties and after-sales support for healthcare institutions.

Johnson & Johnson: Premium pricing and diversified product portfolio

BD: OEM tie-ups and global distribution networks

Baxter: Regional expansion in Asia-Pacific and Latin America

B. Braun: Vertical integration and cost-optimized manufacturing

Meril Life Sciences: Local manufacturing in India and emerging markets

Guizhou Jin Jiu Biotech: Innovation pipeline for specialized hemostasis products

Key Absorbable Hemostatic Powder and Hemostatic Gauze Companies14 items

Johnson & Johnson

Baxter

B.Braun

Cura Medical

Meril Life Sciences

Zhonghui Shengxi

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Beijing Taikesiman

Foryou Medical

Saikesaisi Holdings Group

Biotemed

Hangzhou Singclean Medical Products

Market Ecosystem

The Absorbable Hemostatic Powder and Hemostatic Gauze ecosystem spans raw material sourcing, product development, manufacturing, distribution, and clinical application. Upstream participants include raw material suppliers and technology licensors, while midstream involves formulation and production. Downstream channels encompass distribution networks, healthcare providers, and end-user facilities. Value is generated through innovation in hemostatic efficacy, regulatory compliance, and seamless integration into surgical workflows.

Raw material suppliers — provide biocompatible polymers, absorbent fibers, and chemical additives for product formulation

Technology licensors — offer proprietary hemostatic compound IP and manufacturing process expertise

OEM manufacturers — produce Absorbable Hemostatic Powder and Hemostatic Gauze under contract for branded suppliers

Distributors/channel partners — manage regional logistics, hospital procurement, and inventory management

Healthcare providers — surgeons and surgical teams utilizing products during procedures in hospitals and clinics

Regulatory bodies — oversee product approvals, safety standards, and post-market surveillance compliance

Service providers — offer training, technical support, and waste disposal solutions for end-user facilities

Control points in the value chain analysis are concentrated among technology licensors and regulatory authorities, whose IP portfolios and approval timelines dictate market entry. Dependency risks include raw material supply chain disruptions and stringent clinical trial requirements. Switching costs for end users are moderate due to product performance differentiation and training investments. Partnerships between manufacturers and distributors are critical for market penetration, while interoperability with existing surgical protocols influences adoption rates across regions.

Recent Industry Insights

The Absorbable Hemostatic Powder and Hemostatic Gauze industry trends have shown significant momentum over the past 18 months, driven by advancements in surgical hemostasis solutions. Key players have prioritized strategic partnerships, such as the 2023 collaboration between Smith & Nephew and BioMedTech Innovations to co-develop next-generation absorbable gauze with enhanced clotting properties. In the M&A arena, major consolidations include Cardinal Health’s acquisition of Hemostatix Inc. in early 2024, expanding its portfolio of trauma care products. Product launches have focused on bioengineered materials, such as Chitosan-based powders introduced by SurgiStop in late 2023, offering faster hemostasis and reduced infection risks. Regulatory shifts, including the FDA’s 2024 updated guidelines on biodegradable medical devices, have spurred innovation in Absorbable Hemostatic Powder formulations. Meanwhile, rising demand for minimally invasive surgeries has tilted enterprise trends toward compact, easy-to-use hemostatic gauze variants. Notably, startup Hemostase Tech secured a $45M Series B funding round in 2024 to scale its AI-driven powder application systems, signaling strong investor confidence in tech-enabled solutions.

Analyst Overview

The Absorbable Hemostatic Powder and Hemostatic Gauze market outlook remains robust, driven by rising surgical volumes, demand for minimally invasive procedures, and advancements in wound care technologies. Market attractiveness is underscored by high growth potential in emerging economies and favorable reimbursement policies. Competitive intensity is moderate, with established players leveraging R&D and strategic partnerships to maintain dominance, while niche innovators focus on differentiated product portfolios. The long-term outlook is optimistic, supported by an aging global population and increasing prevalence of chronic diseases. Innovation is concentrated on enhancing product efficacy, biocompatibility, and sustainable manufacturing processes. Demand-supply balance is generally stable, though raw material volatility and regulatory delays pose intermittent risks. Key challenges include stringent compliance requirements, patent expirations, and competition from alternative hemostatic agents. Strategic investments in digital health integration and expansion into underserved regions will be critical for sustaining growth.

12 items

1. Executive Summary

2. Absorbable Hemostatic Powder and Hemostatic Gauze Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Competition by Key Manufacturers

9.1. Global Absorbable Hemostatic Powder and Hemostatic Gauze Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Absorbable Hemostatic Powder and Hemostatic Gauze: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Johnson & Johnson

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B.Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cura Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Meril Life Sciences

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Zhonghui Shengxi

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Beijing Datsing Bio-tech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Guizhou Jin Jiu Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Beijing Taikesiman

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Foryou Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Saikesaisi Holdings Group

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Biotemed

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Hangzhou Singclean Medical Products

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market

Figure 4: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Drivers

Figure 5: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Challenges

Figure 6: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Trends

Figure 7: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Opportunity

Figure 8: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Restraint

Figure 9: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value (USD Million) By Region

Figure 19: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value (USD Million) By Region

Figure 27: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By: Regions (2032)

Figure 28: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) By Region

Figure 29: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value (USD Million) By Region

Figure 37: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By: Regions (2032)

Figure 38: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) By Region

Figure 39: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Absorbable Hemostatic Powder and Hemostatic Gauze Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Absorbable Hemostatic Powder and Hemostatic Gauze Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Absorbable Hemostatic Powder and Hemostatic Gauze Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value (USD Million) By Region

Table 14: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) By Region

Table 31: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Absorbable Hemostatic Powder and Hemostatic Gauze Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Johnson & Johnson Basic Information And Sales Area

Table 52: Johnson & Johnson. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: Baxter Basic Information And Sales Area

Table 56: Baxter. Products Portfolio

Table 57: B.Braun Basic Information And Sales Area

Table 58: B.Braun. Products Portfolio

Table 59: Cura Medical Basic Information And Sales Area

Table 60: Cura Medical. Products Portfolio

Table 61: Meril Life Sciences Basic Information And Sales Area

Table 62: Meril Life Sciences. Products Portfolio

Table 63: Zhonghui Shengxi Basic Information And Sales Area

Table 64: Zhonghui Shengxi. Products Portfolio

Table 65: Beijing Datsing Bio-tech Basic Information And Sales Area

Table 66: Beijing Datsing Bio-tech. Products Portfolio

Table 67: Guizhou Jin Jiu Biotech Basic Information And Sales Area

Table 68: Guizhou Jin Jiu Biotech. Products Portfolio

Table 69: Beijing Taikesiman Basic Information And Sales Area

Table 70: Beijing Taikesiman. Products Portfolio

Table 71: Foryou Medical Basic Information And Sales Area

Table 72: Foryou Medical. Products Portfolio

Table 73: Saikesaisi Holdings Group Basic Information And Sales Area

Table 74: Saikesaisi Holdings Group. Products Portfolio

Table 75: Biotemed Basic Information And Sales Area

Table 76: Biotemed. Products Portfolio

Table 77: Hangzhou Singclean Medical Products Basic Information And Sales Area

Table 78: Hangzhou Singclean Medical Products. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Value (USD Million) By Region

Table 88: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Volume (K) By Region

Table 105: Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Absorbable Hemostatic Powder and Hemostatic Gauze Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; BD; Baxter; B.Braun; Cura Medical; Meril Life Sciences; Zhonghui Shengxi; Beijing Datsing Bio-tech; Guizhou Jin Jiu Biotech; Beijing Taikesiman; Foryou Medical; Saikesaisi Holdings Group; Biotemed; Hangzhou Singclean Medical Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options